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Introduction
Newcastle disease virus (NOV) and
infectious bronchitis virus (IBV) are
economically important poultry vi-
ruses, which are controlled through
vaccination. The haemagglutinin-
neuraminidase (HN) and fusion (F)
proteins of NOV are immunogenic as
well as protective against NO. Their
molecular characterisation is important
in the development of subunit vaccine
against NOV. The multiplicity of se-
rotypes in IBV has made it difficult to
develop any efficacious vaccines. Di-
agnostic techniques are therefore re-
quired to distinguish these viruses. The
objectives of this project are to amplify
and study specific regions in the viral
genomes (for the development of diag-
nostic kits); to clone and express the F
and HN genes into Escherichia coli
and Baculovirus vectors (for the devel-
opment of subunit vaccines); and to
analyse the expressed proteins.
Materials and Methods
Viruses in the study included several
Malaysian lBV and NOV field isolates
and reference strains. The viruses were
grown, purified and their genomic
RNAs were extracted. Primers were
constructed to amplify specific regions
in the genome by RT-PCR. The ampli-
fied products were analysed by restric-
tion enzyme analysis and sequencing.
The S gene of IBV strain MH5365/95
as well as the NP, P, M, F, HN and
parts of the L genes of NOV strain
AF2240 were cloned and sequenced.
Diagnostic kits for IBV and NOV
identification were developed using (i)
universal primers for RT-PCR and (ii)
nested PCR-ELISA respectively. The
HN and F genes of NOV strain
AF2240 were subcloned into the Ba-
culovirus expression system. The ex-
pressed gene products were then stud-
ied in detail. Specific peptides se-
quences which bind to NDV were de-
termined through biopanning with a
phage display library. Various chi-
maeras and mutants are currently being
constructed and their biological func-
tions are determined.
Results and Discussion
Diagnosis of lBV and NDV. Univer-
sal primers were developed to detect
IBV by RT-PCR. The complete se-
quence of the S gene of the IBV
MH5365/95 was determined. Se-
quencing of the cloned S I regions
showed that some of the Malaysian
IBV isolates were similar while others
were to the vaccine strains. The differ-
ent IBV isolates could be distin-
guished. Similarly, various NOV iso-
lates could be distinguished by se-
quence analysis of the cleavage site of
the F protein gene. A nested RT-PCR
ELISA diagnostic kit has been devel-
oped for the determination and identifi-
cation of NDV. This kit is more sensi-
tive and specific then the current sero-
logical tests.
Sequence determinations of the vari-
ous genes of NDV and their expres-
sions. The sequences of all the genes
of velogenic-viscerotropic NOV strain
AF2240, except the L gene, have been
completely determined and each given
EMBLlGenBank database accession
numbers. The HN, F, NP and P gene
sequences have been published and the
remaining gene sequences are in the
process of being published. The HN
gene of the heat stable V4(UPM) as
well as strain AF2240 had deletions at
the Arg 403 residue. However, this
may not be entirely responsible for heat
stability. The NP and P gene se-
quences have been filed for patents in
Malaysia and US. The NP protein was
expressed in E. coli as ring and her-
ringbone-like structures. These struc-
tures were shown to be able to carry
extra peptide fragments at the C-
terminal end.
Cloning and expression of HN and F
genes of NDV. The HN and F genes of
strain AF2240 were amplified by RT-
PCR and cloned into E. coli and
PCR TM Bac baculovirus transfer vec-
tors (Invitrogen). The recombinant
plasmids were co-transfected with
triple cut, linearised Bac-N-Blue TM
AcMNPV (Invitrogen) DNA into
Spodoptera frugiperda (SF9) insect
cells using cationic liposome mediated
transfection method. The recombinant
proteins expressed in the Baculovirus
system are currently being analysed.
The recombinant HN protein has been
shown to be immunogenic. The HN
genes ofV4(UPM), V4(QUE) and
AF2240 have also been cloned into
Baculovirus and the expressed recom-
binant proteins were studied for the
heat stability. In addition, the HN and
F genes have also been cloned into
Pichia pastoris and eukaryotic expres-
sion vectors for the development of
alternative recombinant vaccines.
Some positive results have been ob-
tained for these recombinant proteins
expressed as DNA vaccines. The ex-
pression of these proteins in E. coli are
being studied in detail.
NDVproteins interactions: Work on
the protein-protein interactions of the
recombinant proteins are being carried
out to determine the mechanism(s) of
virus-cell interactions. The NOV re-
ceptors are being studied through
biopanning with a phage display li-
brary. Two anti-NOV peptides have
been constructed and shown to inhibit
NOV replication. Chimaeras com-
prising various NOV protein segments
with the NP protein have been con-
structed and their immunogenicity
tested. These results are in the process
of being published and a patent is being
filed in Malaysia and the US.
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Conclusions
Diagnostic tests for IBV and NI)\
have been developed. The complete
sequences of the NP. P, M, F and HN
genes of NOV strain AF2240 and S
gene of!BV strain M5365/95 were
determined and given EMBUGenBank
database accession numbers. Strain
AF2240 differed in the length of the
HN protein and the absence of the Arg
(403) residue in the F protein. The F
and HN genes of NOV strain AF2240
were cloned and expressed in the Ba-
cu/ovirus, E. coli, yeast and other ex-
pression systems. Anti-NOV peptides
have been developed. The receptor and
protein-protein interactions of the NOV
proteins are being studied in detail.
The NP protein can be expressed as a
ring structure in E. coli and may be
suitable as a carrier in future drug de-
livery system.
Benefits from the study
Development of diagnostic kits and
subunit vaccines for NOV and IBV;
patents for the peR-ELISA kit and NP
and P gene sequences; and training of
molecular biologists.
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